NCKU Seals Technology Transfer Agreement With Vedan

NCKU has signed a Technology Transfer Agreement with Vedan International. The agreement marks a successful transfer of NCKU’s microalgal DHA (docosahexaenoic acid) production technology, developed by Huey-Lang Yang’s Aquatic Animal Bio-Medicine R&D Team, to Vedan Biotechnology, a subsidiary company of Vedan International.

DHA is an important nutrient for growth and development of human, animal and fish from youth to elder. DHA does not only improve the growth of babies and young child’s brain, retinal development, but also prevents cardiovascular disease, depression, Alzheimer’s disease and other chronic diseases.

Michael Ming-Chiao Lai, president of NCKU, said that the collaboration between NCKU and Vedan is a good example of industry-academia cooperation. He also praised that Prof. Yang has not only made breakthroughs in aquiculture and biotechnology industry and great contributions to ecology and human health, but also demonstrated his great creativity in producing DHA from microalgae, instead of fishes and marine animals.

Tou-Hsiung Yang, chairman of Vedan International, felt very excited to have speedy development in cooperation with NCKU for the first time. He commended the research capability of NCKU’s AABM Team, especially on the rapid isolation of indigenous DHA producing microalgae BL 10 and associative research development on DHA production. He has also promised to market the BL 10 produced DHA with Vedan, and indicated that Vedan is always looking forward to having more opportunities in collaboration with NCKU in the future.